@FierceMedDev: "Brain window" implant could enable targeted treatments. Item | Follow @FierceMedDev
@MarkHFierce: bioMerieux's $450M BioFire Dx buy gives it an even greater foothold in infectious disease diagnostics. Story | Follow @MarkHFierce
> Women are 25% less likely than men to die one year after transcatheter aortic valve implantation (TAVI), according to new research presented at the ESC Congress 2013 in Amsterdam. Item
> Sony is looking at using its image sensors, in part, for new medical equipment. Story
> The FDA is looking at how it might evaluate medical devices made using 3D printers. Story
> Researchers at Brigham and Women's Hospital in Boston have developed a diagnostic risk score calculation that can help predict which patients are at risk of kidney failure or death after injury. Item
> Purview in Crofton, MD, is launching a new medical image storage and sharing platform--a cloud-based system designed to give patients more control over their medical records. Item
> Coherex Medical won a CE mark for its new left atrial appendage occlusion sytem, which is designed to help treat atrial fibrillation. Item
Biotech News
@FierceBiotech: AstraZeneca rolls the dice (again) on a failed cancer drug. More | Follow @FierceBiotech
@JohnCFierce: Be sure to check out our new weekly report: FierceDiagnostics | Follow @JohnCFierce
@RyanMFierce: Rare diabetes drug development startup Elcelyx Tx spins off nutraceutical assets into NaZura BioHealth. Release | Follow @RyanMFierce
@EmilyMFierce: Altered gene in mice extends lifespan by 20%. Story | Follow @EmilyMFierce
> Pursuing Alzheimer's, iPierian grabs $30M and spins off orphan drug biotech. More
> Transgene, Jennerex ponder fate of tumor-fighting virus after PhIIb failure. Story
> Rockwell Medical surges on more promising PhIII data for iron-delivery drug. Article
> BioMérieux to fork over $450M for Utah Dx outfit. News
Pharma News
@FiercePharma: India approves $1.6bn acquisition of Agila Specialties by Mylan. More | Follow @FiercePharma
@EricPFierce: ICYMI: Indian regulators find no serious problems at Wockhardt plant banned by FDA. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: How a peptide and a protein can help predict heart attack--and ease overcrowding in the emergency room. More from FierceBiomarkers | Follow @CarlyHFierce
> Onyx CEO Tony Coles will score $58M on Amgen deal. Story
> China talks about massive fines against GSK. More
> Eli Lilly's Alimta gains may cause Princeton pain. Article
Drug Delivery News
@MichaelGFierce: Self-powered nanomeds deliver bone-strengthening drugs. Article | Follow @MichaelGFierce
> Oramed submits pre-IND for oral exenatide Type 2 diabetes pill. More
> Meda buys Acton for $135M+, snags asthma inhaler. Item
> Google invests in oral drug delivery for insulin, other biologics. Story
> Nanosized DNA cages could deliver drugs with triggered release. Report
> Novan collects $7.8 million from gov to develop nitric oxide burn med. News
Diagnostics News
> BioFire Diagnostics keeps identity in $450M bioMérieux deal. Story
> Indian Dx giant emerges. Article
> ITC, Accumetrics merge with eye on global cardiovascular Dx. News
> Study: PET/MRI combo adds heft in cancer Dx. Report
> Cepheid wins key "moderate complexity" designation for combo TB test. More
> Siemens co-develops Alzheimer's blood test. Item
Biomarkers News
> Biomarker sorely needed for diagnosing chronic migraines. Story
> Heart attack biomarker could ease ER crowding. News
> Researchers zero in on biomarker for early diagnosis of ovarian cancer. Report
> Blood test flags organ transplant injury. Item
> Study: Protein may predict mesothelioma survival. More
> Biomarker test boosts prospects for Parkinson's prediction. Article